0001140361-11-034370.txt : 20110628 0001140361-11-034370.hdr.sgml : 20110628 20110628103732 ACCESSION NUMBER: 0001140361-11-034370 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110628 DATE AS OF CHANGE: 20110628 EFFECTIVENESS DATE: 20110628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-156147 FILM NUMBER: 11934680 BUSINESS ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-806-4304 MAIL ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 D/A 1 primary_doc.xml X0704 D/A LIVE 0001348649 CoLucid Pharmaceuticals, Inc. 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC NORTH CAROLINA 27713 919-806-4304 DELAWARE Colucid Pharmaceuticals Inc. Colucid Pharmaceuticals Inc Corporation true Arthur M. Pappas Pappas Ventures, 2520 Meridian Parkway Suite 400 Durham NC NORTH CAROLINA 27713 Executive Officer Director Thomas P. Mathers 2530 Meridian Parkway Suite 300 Durham NC NORTH CAROLINA 27713 Executive Officer Director Jesse I. Treu One Palmer Square Suite 515 Princeton NJ NEW JERSEY 08542 Director Richard J. Markham 47 Hulfish Street Suite 310 Princeton NJ NEW JERSEY 08542 Director Timothy C. Gupton 1500 Sunday Drive Suite 300 Raleigh NC NORTH CAROLINA 27607 Executive Officer Nadia M. Rupniak 2530 Meridian Parkway Suite 300 Durham NC NORTH CAROLINA 27713 Executive Officer Pharmaceuticals $1 - $1,000,000 06 true 0001140361-11-013783 2011-02-25 false true true false 0 9500000 3500000 6000000 $2,000,000 was sold on February 25, 2011. A Form D was filed at that time. $1,500,000 was sold on June 15, 2011. false 7 0 0 0 No proceeds are proposed to be used for payment to such persons other than ordinary salary expenses that may be paid out of working capital. false CoLucid Pharmaceuticals, Inc. Timothy C. Gupton Timothy C. Gupton Chief Financial Officer 2011-06-27